Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
Pasvolsky O, Milton DR, Masood A, Sami SS, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Saeed A, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Among authors: tanner mr. Am J Hematol. 2023 Oct;98(10):1571-1578. doi: 10.1002/ajh.27029. Epub 2023 Jul 17. Am J Hematol. 2023. PMID: 37461327
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
Pasvolsky O, Saliba RM, Masood A, Mohamedi AH, Tanner MR, Bashir Q, Srour S, Saini N, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Among authors: tanner mr. Br J Haematol. 2023 May;201(4):e37-e41. doi: 10.1111/bjh.18753. Epub 2023 Mar 14. Br J Haematol. 2023. PMID: 36916461 No abstract available.
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant.
Pasvolsky O, Marcoux C, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Tewari P, Crawford-Suber L, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Among authors: tanner mr. Br J Haematol. 2023 Aug;202(4):866-873. doi: 10.1111/bjh.18944. Epub 2023 Jun 27. Br J Haematol. 2023. PMID: 37376789
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
Alzahrani K, Pasvolsky O, Wang Z, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Manasanch EE, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin R, Qazilbash MH. Alzahrani K, et al. Among authors: tanner mr. Br J Haematol. 2024 Mar 6. doi: 10.1111/bjh.19384. Online ahead of print. Br J Haematol. 2024. PMID: 38448009
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
Pasvolsky O, Ghanem S, Milton DR, Rauf M, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Khan HN, Kebriaei P, Lee HC, Patel KK, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Among authors: tanner mr. Blood Cancer J. 2024 Jan 10;14(1):4. doi: 10.1038/s41408-023-00973-w. Blood Cancer J. 2024. PMID: 38199987 Free PMC article.
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
Pasvolsky O, Pasyar S, Bassett RL, Khan HN, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Among authors: tanner mr. Cancer. 2024 May 1;130(9):1663-1672. doi: 10.1002/cncr.35171. Epub 2023 Dec 21. Cancer. 2024. PMID: 38127583
Inequities Along the Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Services Continuum for Black Women in the United States, 2015-2020.
Townes A, Tanner MR, Yu L, Johnson WD, Zhu W, Iqbal K, Dominguez KL, Henny KD, Drezner K, Schumacher C, Bickham J, Elopre L, Edelstein ZR, Hoover KW; Targeted Highly Effective Interventions to Reverse the HIV Epidemic (THRIVE) Project Team*. Townes A, et al. Among authors: tanner mr. Obstet Gynecol. 2024 Feb 1;143(2):294-301. doi: 10.1097/AOG.0000000000005451. Epub 2023 Nov 14. Obstet Gynecol. 2024. PMID: 37963384
HIV Preexposure Prophylaxis Provision among Adolescents: 2018 to 2021.
Kimball AA, Zhu W, Leonard J, Wei W, Ravichandran I, Tanner MR, Huang YA, Hoover KW, Kourtis AP. Kimball AA, et al. Among authors: tanner mr. Pediatrics. 2023 Nov 1;152(5):e2023062599. doi: 10.1542/peds.2023-062599. Pediatrics. 2023. PMID: 37899721
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma.
Pasvolsky O, Ghanem S, Milton DR, Masood A, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Among authors: tanner mr. Transplant Cell Ther. 2023 Dec;29(12):757-762. doi: 10.1016/j.jtct.2023.08.031. Epub 2023 Sep 4. Transplant Cell Ther. 2023. PMID: 37673125
Benefits of Frequent HIV Testing in the THRIVE Demonstration Project: United States, 2015-2020.
Kimball AA, Zhu W, Yu L, Tanner MR, Iqbal K, Dominguez KL, Shankar A, Drezner K, Musgrove K, Mayes E, Robinson WT, Schumacher C, Delaney KP, Hoover KW; THRIVE Project Team. Kimball AA, et al. Among authors: tanner mr. Am J Public Health. 2023 Sep;113(9):1019-1027. doi: 10.2105/AJPH.2023.307341. Epub 2023 Jul 6. Am J Public Health. 2023. PMID: 37410983
50 results